233 related articles for article (PubMed ID: 24530737)
21. Differential activation of NF-κB signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells.
Gaikwad SM; Thakur B; Sakpal A; Singh RK; Ray P
Int J Biochem Cell Biol; 2015 Apr; 61():90-102. PubMed ID: 25681684
[TBL] [Abstract][Full Text] [Related]
22. Targeting endothelin-1 receptor/β-arrestin1 network for the treatment of ovarian cancer.
Rosanò L; Cianfrocca R; Sestito R; Tocci P; Di Castro V; Bagnato A
Expert Opin Ther Targets; 2017 Oct; 21(10):925-932. PubMed ID: 28758529
[TBL] [Abstract][Full Text] [Related]
23. Comparison of human ETA and ETB receptor signalling via G-protein and β-arrestin pathways.
Maguire JJ; Kuc RE; Pell VR; Green A; Brown M; Kumar S; Wehrman T; Quinn E; Davenport AP
Life Sci; 2012 Oct; 91(13-14):544-9. PubMed ID: 22480514
[TBL] [Abstract][Full Text] [Related]
24. Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway.
Zhang S; Leng T; Zhang Q; Zhao Q; Nie X; Yang L
Biomed Pharmacother; 2018 Jun; 102():302-308. PubMed ID: 29571014
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II activates NF-κB through AT1A receptor recruitment of β-arrestin in cultured rat vascular smooth muscle cells.
Morinelli TA; Lee MH; Kendall RT; Luttrell LM; Walker LP; Ullian ME
Am J Physiol Cell Physiol; 2013 Jun; 304(12):C1176-86. PubMed ID: 23576578
[TBL] [Abstract][Full Text] [Related]
26. beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha.
Witherow DS; Garrison TR; Miller WE; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8603-7. PubMed ID: 15173580
[TBL] [Abstract][Full Text] [Related]
27. The β-arrestin1/endothelin axis bolsters ovarian fibroblast-dependent invadosome activity and cancer cell metastatic potential.
Del Rio D; Masi I; Caprara V; Ottavi F; Albertini Petroni G; Salvati E; Trisciuoglio D; Giannitelli SM; Bagnato A; Mauri E; Spadaro F; Rosanò L
Cell Death Dis; 2024 May; 15(5):358. PubMed ID: 38777849
[TBL] [Abstract][Full Text] [Related]
28. [Effects of PI3K/Akt/NF-κB signal pathway on FSH facilitation on cell proliferation and invasion by human epithelial ovarian cancer].
Xu CL; Lu XL; Yan XN; Wang HL; Chen SQ
Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):134-8. PubMed ID: 22455747
[TBL] [Abstract][Full Text] [Related]
29. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.
Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A
Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476
[TBL] [Abstract][Full Text] [Related]
30. The endothelin A receptor and epidermal growth factor receptor signaling converge on β-catenin to promote ovarian cancer metastasis.
Cianfrocca R; Tocci P; Spinella F; Di Castro V; Bagnato A; Rosanò L
Life Sci; 2012 Oct; 91(13-14):550-6. PubMed ID: 22480520
[TBL] [Abstract][Full Text] [Related]
31. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
Bagnato A; Rosanò L
Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
[TBL] [Abstract][Full Text] [Related]
32. Macitentan blocks endothelin-1 receptor activation required for chemoresistant ovarian cancer cell plasticity and metastasis.
Sestito R; Cianfrocca R; Rosanò L; Tocci P; Di Castro V; Caprara V; Bagnato A
Life Sci; 2016 Aug; 159():43-48. PubMed ID: 26776834
[TBL] [Abstract][Full Text] [Related]
33. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis.
Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X
Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511
[TBL] [Abstract][Full Text] [Related]
34. Pyridoxine 5'-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer.
Zhang L; Zhou D; Guan W; Ren W; Sun W; Shi J; Lin Q; Zhang J; Qiao T; Ye Y; Wu Y; Zhang Y; Zuo X; Connor KL; Xu G
Cell Death Dis; 2017 Dec; 8(12):3214. PubMed ID: 29238081
[TBL] [Abstract][Full Text] [Related]
35. β-arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury.
Buelli S; Rosanò L; Gagliardini E; Corna D; Longaretti L; Pezzotta A; Perico L; Conti S; Rizzo P; Novelli R; Morigi M; Zoja C; Remuzzi G; Bagnato A; Benigni A
J Am Soc Nephrol; 2014 Mar; 25(3):523-33. PubMed ID: 24371298
[TBL] [Abstract][Full Text] [Related]
36. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.
Kim KH; Park SH; Do KH; Kim J; Choi KU; Moon Y
Oncotarget; 2016 Nov; 7(44):72148-72166. PubMed ID: 27708225
[TBL] [Abstract][Full Text] [Related]
37. Functional interaction between endothelin-1 and ZEB1/YAP signaling regulates cellular plasticity and metastasis in high-grade serous ovarian cancer.
Sestito R; Tocci P; Roman C; Di Castro V; Bagnato A
J Exp Clin Cancer Res; 2022 Apr; 41(1):157. PubMed ID: 35477522
[TBL] [Abstract][Full Text] [Related]
38. PSMB4 expression associates with epithelial ovarian cancer growth and poor prognosis.
Liu R; Lu S; Deng Y; Yang S; He S; Cai J; Qiang F; Chen C; Zhang W; Zhao S; Qian L; Mao G; Wang Y
Arch Gynecol Obstet; 2016 Jun; 293(6):1297-307. PubMed ID: 26439929
[TBL] [Abstract][Full Text] [Related]
39. Endothelin Receptor Down-Regulation Mediated Ligand Regulation Mechanisms Protect Against Cellular Hypoxia Injury in Rat Vascular Endothelial Cells.
Li L; Hu M; Zheng L; Zhang C; Li J; Rong R; Zhu T; Jia Y
Cell Physiol Biochem; 2016; 40(6):1443-1454. PubMed ID: 27997891
[TBL] [Abstract][Full Text] [Related]
40. Suppression of Pax2 Attenuates Allodynia and Hyperalgesia through ET-1-ETAR-NFAT5 Signaling in a Rat Model of Neuropathic Pain.
Tai LW; Pan Z; Sun L; Li H; Gu P; Wong SSC; Chung SK; Cheung CW
Neuroscience; 2018 Aug; 384():139-151. PubMed ID: 29847776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]